Apyx Medical (APYX) Cash from Investing Activities Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.76% |
| Dec 31, 2025 | 6.65% |
| Sep 30, 2025 | -125.00% |
| Jun 30, 2025 | -23.03% |
| Mar 31, 2025 | 9.38% |
| Dec 31, 2024 | -1.72% |
| Sep 30, 2024 | 22.80% |
| Jun 30, 2024 | -14.95% |
| Mar 31, 2024 | -14.89% |
| Dec 31, 2023 | 56.77% |
| Sep 30, 2023 | -14.93% |
| Jun 30, 2023 | 107.91% |
| Mar 31, 2023 | 4.57% |
| Dec 31, 2022 | 5.95% |
| Sep 30, 2022 | 7.66% |
| Jun 30, 2022 | -38.04% |
| Mar 31, 2022 | -31.48% |
| Dec 31, 2021 | -26.13% |
| Sep 30, 2021 | -3.81% |
| Jun 30, 2021 | -7.71% |
| Mar 31, 2021 | -55.67% |
| Dec 31, 2020 | -4.12% |
| Sep 30, 2020 | 42.40% |
| Jun 30, 2020 | 14.69% |
| Mar 31, 2020 | 18.74% |
| Dec 31, 2019 | 6.27% |
| Sep 30, 2019 | -29.20% |
| Jun 30, 2019 | 240.37% |
| Mar 31, 2019 | 208.60% |
| Dec 31, 2018 | -104.78% |
| Mar 31, 2018 | -1.19% |
| Dec 31, 2017 | 8.69% |
| Sep 30, 2017 | -11.57% |
| Jun 30, 2017 | -12.70% |
| Mar 31, 2017 | 21.81% |
| Dec 31, 2016 | -4.61% |
| Sep 30, 2016 | 6.56% |
| Jun 30, 2016 | 35.98% |
| Mar 31, 2016 | 22.48% |